The trouble with this new study published is that:
1) It's in vitro. (In other words, the science is done in glass. It's not a clinical trial involving patients.)
2) It involved clioquinol, the "forerunner" of PBT2.
Sure, it's nice to see the results. But really, this stuff was already known (otherwise they wouldn't have progressed to PBT2.)
We're waiting for the 3-course meal featuring soup, steak and dessert and we've just been served a (red) herring...
Just my opinion.
The Cat
- Forums
- ASX - By Stock
- new independent study
The trouble with this new study published is that:1) It's in...
Featured News
Add ATH (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.3¢ | $3.171K | 1.057M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
61 | 80531900 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 2600832 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
61 | 80531900 | 0.002 |
23 | 125810099 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 2607735 | 3 |
0.004 | 137755246 | 31 |
0.005 | 21959256 | 23 |
0.006 | 22031950 | 18 |
0.007 | 50806651 | 22 |
Last trade - 12.37pm 18/09/2024 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |